Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, her2-positive early breast cancer: Results from the BCIRG 006 study

Background. This study aims to describe and compare health- related quality of life (HRQL) in patients with node-positive and high-risk node-negative HER2-positive early breast can-cer receiving adjuvant docetaxel and trastuzumab-based or docetaxel-based regimens alone. Methods. Eligible patients (n...

Full description

Bibliographic Details
Main Authors: Au, H., Eiermann, W., Robert, N., Pienkowski, T., Crown, J., Martin, M., Pawlicki, M., Chan, Arlene, Mackey, J., Glaspy, J., Pintér, T., Liu, M., Fornander, T., Sehdev, S., Ferrero, J., Bée, V., Santana, M., Miller, D., Lalla, D., Slamon, D.
Format: Journal Article
Published: AlphaMed Press 2013
Online Access:http://hdl.handle.net/20.500.11937/12232

Internet

http://hdl.handle.net/20.500.11937/12232

Similar Items